Group One Trading’s Acurx Pharmaceuticals ACXP Stock Holding History

Group One Trading’s Portfolio ACXP Stock Details ACXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147	Sell	95 -150	-61%	-$312	﹤0.01%	7387
2026 Q1	$909	Sell	245 -38	-13%	-$108	﹤0.01%	7226
2025 Q4	$705	Sell	283 -15	-5%	-$72	﹤0.01%	7766
2025 Q3	$1.28K	Sell	298 -382	-56%	-$2.3K	﹤0.01%	8013
2025 Q2	$6.95K	Buy	680 +622	+1,072%	+$5.01K	﹤0.01%	6932
2025 Q1	$454	Hold	58	–	–	﹤0.01%	7289
2024 Q4	$948	Buy	58 +49	+544%	+$1.48K	﹤0.01%	6901
2024 Q3	$329	Sell	9 -252	-97%	-$10.7K	﹤0.01%	6422
2024 Q2	$11.8K	Sell	261 -413	-61%	-$18.2K	﹤0.01%	5558
2024 Q1	$33K	Buy	+674	New	+$43.8K	﹤0.01%	5045
2023 Q4	–	Sell	-30	Closed	-$2.26K	–	7291
2023 Q3	$858	Buy	+30	New	+$1.15K	﹤0.01%	7244

Other funds holding ACXP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PFS

Prospect Financial Services Melville, New York $197M AUM 24.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Group One Trading's ACXP Position: Q2 2026 in Review

Group One Trading reduced its Acurx Pharmaceuticals (ACXP) stake by 61% in Q2 2026, selling an estimated $312 and leaving 95 shares worth $147. The position accounts for ﹤0.01% of the portfolio, ranked #7387.

Group One Trading first reported a position in ACXP in Q3 2023 and has held it in 11 quarters since. The position peaked at $33K in Q1 2024. 19 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.

Group One Trading held 95 shares of Acurx Pharmaceuticals worth $147 as of Q2 2026.
Group One Trading sold 150 Acurx Pharmaceuticals shares in Q2 2026, an estimated $312.
Acurx Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7387 holding.
Group One Trading first reported a position in Acurx Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
Group One Trading's Acurx Pharmaceuticals position peaked at $33K in Q1 2024.
19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.